Oncotyrol is the Austrian address for translational research in personalized cancer medicine. We are based on the outstanding basic research and long-lasting experience in clinical oncology in Tyrol. From here we reach out to connect scientific, clinical and industrial partners
We believe that clinical benchmarking is the key to efficiency and success. The needs of clinicians treating cancer patients on a day-to-day basis are permanently fed back into our development process. From bench to bedside and back is our philosophy.
The Tyrolean Cancer Research Center Oncotyrol participates in the 4.8 million-Horizon 2020- project PERMIDES (Personalised Medicine Innovation through Digital Enterprise Solution). Under the project lead of the Software Cluster of the Technical University of Darmstadt the PERMIDES project will be